Patent · US Active

Prevention of thrombus formation and/or stabilization with inhibitors of factor XII or activated factor XII

US8119137B2 · kind B2 · utility

6Cited by

3References

12Claims

0Family size

Assignee

CSL Behring AG · DE

Inventors

Bernhard Nieswandt · Eibelstadt, DE
Thomas Renné · Bad Sobernheim, DE

Key dates

Filing date	Dec 20, 2005
Grant date	Feb 21, 2012
Priority date	—
Expiry date	Nov 11, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of at least one antibody and/or one inhibitor for inhibiting factor XII and preventing the formation and/or the stabilization of three-dimensional thrombi. It also relates to a pharmaceutical formulation and the use of factor XII as an anti-thrombotic target.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.